Current role
CFO, Chief Accounting Officer, Board Member
2024-01-01–present
Mary Kay Fenton
Chief Accounting Officer
Cullinan Therapeutics, Inc. (CGEM)Board Member
Cullinan Therapeutics, Inc. (CGEM)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-04-29–present
-
Current
2024-04-29–present
-
Current
2024-01-01–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | $512,325 | $2,078,837 |
| 2024 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | $333,808 | $4,142,413 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.